Pages
Join with colleagues to remember and reflect
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/join-colleagues-remember-and-reflect
Temporary Annual Leave Measures 2022
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/temporary-annual-leave-measures-2022
Files
Disclosure Ref 2024229 - Ophthalmology services.pdf
Freedom of Information disclosure reference 2024229 relating to ophthalmology services and patients being treated for wet-AMD
Disclosure Ref 2024219 - Off framework and framework .pdf
Freedom of information disclosure reference 2024219 relating to Off Framework and Framework Agency spend solely for Nurses from 1st April 2023 to 1st May 2024
Disclosure Ref 2025194 - Ambulance call-out requests from stadiums on matchdays.pdf
Freedom of Information disclosure reference 2025194 relating to ambulance call-out requests from stadiums on matchdays
Flu Vaccine - FAQ information for DCHS staff 2025-26 (G346)
The document provides comprehensive information about the flu vaccine for DCHS staff for the 2025-26 season. It addresses various frequently asked questions (FAQs) related to the administration of the flu vaccine, including eligibility criteria, safety for specific groups (such as pregnant women, individuals with egg or latex allergies, and those with religious or dietary restrictions), and guidelines for staff who are administering the vaccine. The document also provides information on handling the vaccine, necessary personal protective equipment (PPE), and procedures for dealing with anaphylaxis. Additionally, the document includes resources and standard operating procedures (SOPs) for staff involved in the vaccination process.
Disclosure Ref 2024251 - Sexual Safety incidents patients aged 60+.pdf
Freedom of Information disclosure relating to sexual safety incidents where the alleged victim was over 60 or over
Disclosure Ref 2025190 - Contracts & Purchases for ID cards, Lanyards and Access Control Supplies .doc
Freedom of Information disclosure relating to contracts & purchases for ID cards, lanyards and access control supplies
Disclosure Ref 2025235 - NexGen knee replacements.doc
Freedom of information disclosure relating to NexGen knee replacements
Disclosure Ref 2025272 - Therapy and Community Rehabilitation services, including Occupational Therapy, Physiotherapy, Speech and Language Therapy, and Dietetics.doc
Freedom of information relating to Therapy and Community Rehabilitation services, including Occupational Therapy, Physiotherapy, Speech and Language Therapy, and Dietetics
Management of Under Nutrition in Adults (G43)
The aim of the guidelines is to ensure effective patient centred oral nutrition support in Derbyshire by promoting a fortified diet and appropriate, effective ONS prescribing.
Venous Thromboembolism (VTE) Prophylaxis Policy (P8)
Venous Thromboembolism (VTE) is a leading cause of avoidable death in the UK. It is estimated that VTE causes in excess of 25,000 potentially preventable deaths per annum in UK hospitals – five times the estimated number of deaths each year from hospital-acquired infection. In the UK as a whole this figure is approximately 60,000 preventable deaths each year (DH, 2007). The implementation of evidence based guidelines first published by the National Institute of Clinical Excellence (NICE) in 2010 focussing on the prevention of VTE in hospitalised patients has been afforded a high priority by the Department of Health and commissioners. VTE risk assessment is a former national CQUIN indicator and is a National Quality Requirement in the NHS Standard Contract for 2019/20 (NHSE, 2019). It sets a threshold rate of 95% of adult inpatients being risk assessed for VTE on admission each month. This policy and the accompanying clinical documentation will enable clinicians to reduce mortality and morbidity associated with this VTE through screening patients admitted for day surgery or inpatient care and those attending Minor Injury Unit / Urgent Treatment Centres, educating patients and carers about preventative measures, initiating prophylactic treatment and recognising signs of VTE development.